Development and Evaluation of Aspirin-Neem oil based Emulgel for Wound Healing
Iftesam Samir Momin1, Sayali Suresh Patil2, Amruta Zakas Patil3, Vaishnavi Pandurang Khot4, Gayatri Vijay Farakate5, Dhanraj Raghunathrao Jadge6, Shalini Ashok Shinde7,
Aniket Chandrakant Thanekar8*
Department of Pharmaceutical Chemistry, Womens College of Pharmacy, Peth-Vadgaon 416112, India.
1ORCIDs: 0009-0001-2873-3180, 2ORCIDs: 0009-0003-4475-3004,3ORCIDs: 0009-0008-5228-5251,
4ORCIDs: 0009-0008-5462-0551, 5ORCIDs: 0009-0002-9402-8719,6ORCIDs: 0000-0003-3979-1682,
7ORCIDs: 0009-0001-8322-5007, 8ORCIDs: 0009-0003-3806-0017
*Corresponding Author E-mail: ms.shalinishinde177@gmail.com, athanekar01@gmail.com
ABSTRACT:
The creation of innovative medication delivery systems is a result of the increased interest in mixing synthetic and herbal medicines for improved therapeutic effects. This study aims to develop and assess a topical emulgel for wound healing and anti-inflammatory applications that combines neem oil, a traditional herbal treatment, with aspirin, a well-known NSAID. In addition to specific emulsifiers, humectants, and penetration enhancers, Carbopol 930 was used as a gelling agent in the formulation's preparation. The F1 formulation outperformed the other two batches in terms of physicochemical properties, such as pH, viscosity, spreadability, and extrudability. Studies on in vitro permeation showed a biphasic drug release profile, with the highest absorption occurring after three hours. Significant antibacterial efficacy against Escherichia coli was demonstrated by the formulation, along with thermal stability, with a maximum inhibition zone. These findings imply that the aspirin-neem oil emulgel combines the advantages of synthetic and herbal pharmacotherapy to provide a promising dual-action therapeutic alternative for localized inflammation and infection control.
KEYWORDS: Emulgel, Anti-inflammatory, Herbal-Synthetic combinations, Anti-bacterial activity, Skin permeation, Dual action.
INTRODUCTION:
There are several analgesic medicines are available in the market in various topical forms. Aspirin, which is a synthetic drug, technically known as acetylsalicylic acid, has been extensively used in various fields of medicine. Its natural source is the willow tree bark, which has been known since ancient times for its therapeutic value.1
Willow bark was used to reduce inflammation, consistent with the later-known anti-inflammatory effects of salicylates and aspirin.2 The other ingredient, Neem oil, is a herbal drug that comes from the tree of neem, Azadirachta indica Juss., of the family Meliaceae. Indigenous to the Indian subcontinent.3 Neem oil and leaf extracts have antibacterial properties that work against a variety of germs, including some that are resistant to drugs. They work on both Gram-positive and Gram-negative bacteria, such as Mycobacterium tuberculosis, Vibrio cholerae, and Klebsiella pneumoniae. A specific compound called limonoid in neem shows particularly strong antibacterial effects.4
Definition of emulgel:
Emulgels are categorized as either water-in-oil or oil-in-water systems, created by incorporating a gelling agent. In the pharmaceutical field, both types are widely utilized for delivering medications to the skin. A notable characteristic of emulgels is their ability to penetrate the skin with ease. When a gelling agent is added to the water phase, it leads to the formation of a standard emulsion, which is then known as an emulgel.5 One of the main advantages of topical administration is its ability to bypass the first-pass metabolism. Additional benefits include avoiding the risks and inconveniences associated with intravenous therapies, as well as minimizing issues related to absorption, such as variations in pH, enzymatic activity, and gastric emptying time. People frequently apply a range of dermatological and cosmetic products to either healthy or affected skin.6
Advantages:
1. First-pass metabolism should be avoided.
2. Avoiding incompatibilities with the gastric tract.
3. More site-specific.
4. Boost patient adherence.
5. Appropriateness for self-administration.
6. Enabling the use of medications having a limited therapeutic window and a brief biological half-life.
7. The ability to quickly stop taking medication when necessary
8. Convenient and simple to use.
9. Including hydrophobic medications
10. Increased loading capacity and improved stability7
Disadvantages:
1. Contact dermatitis causes skin inflammation.
2. The potential for allergic responses.
3. Certain medications' poor skin permeability.
4. Large-particle drugs are difficult for the skin to absorb.
5. The bubble's appearance during emulgel creation7
A drug employed for the relief of pain, fever, inflammation, and headache, as well as for the prevention of heart attacks, strokes, and other occurrences. Acetylsalicylic acid (ASA), or Aspirin, is a very common drug for the relief of pain and fever due to many conditions. It possesses both anti-inflammatory and antipyretic effects.8 Neem is an active chemical agent with known antiulcer, anti-inflammatory, antiseptic, antiviral, antipyretic, and antifungal activities present in the majority of parts of the plants, such as fruit, leaves, bark, seeds, and roots.9 In the event of Wound healing, Neem fights off bacteria and facilitates regeneration, and Aspirin reduces inflammation and could enhance blood flow by regulation of prostaglandins. It may encourage cleaner or faster healing. To create synergistic anti-inflammatory and antimicrobial effects, uniting conventional medicine with traditional medicine.
Aspirin and Neem oil both are known for their healing properties. Specially for reducing inflammation and fighting infections. However, there are very few or no products that combine both of these ingredients in an emulgel. Most available products use them separately, and there is not much research on how well they might work together in a single emulgel formulation. This study was done to formulate a new emulgel that combines aspirin and neem oil. The goal is to take advantage of both ingredients to make a product that works better for reducing pain, swelling, and in wound healing. Emulgels help the medicine absorb better through the skin and give longer-lasting effects. Using both a synthetic drug and a herbal drug may also help reduce side effects and make the product safer and more effective.
Rationale for Combining Herbal and Synthetic Drugs:
Effects of Synergistic Therapy:
One of the primary justifications for mixing synthetic and natural drugs is the potential for synergistic effects. When taken together, certain herbal active components can enhance the pharmacological effect of synthetic drugs, boosting their therapeutic efficacy in comparison to when given alone. Take, for example, the anti-inflammatory synergy of the herbal curcumin and the synthetic diclofenac. Herbal treatments may improve the primary effects of synthetic medications by changing inflammatory pathways or oxidative stress.
Dose Reduction and Minimization of Side Effects: Herbal medicines may enable a decrease in the dosage of the synthetic drug required to achieve the same effect by enhancing the overall therapeutic impact. This can lower drug toxicity, lessen systemic side effects, and increase security, especially for topical treatment over an extended period of time.
Multifunctional Activity:
Herbal medicines often exhibit a wide range of biological actions, such as anti-inflammatory, antioxidant, antibacterial, and wound-healing qualities. When combined with target-specific synthetic drugs, the result is a multifunctional formulation that addresses multiple aspects of an issue.10
MATERIALS AND METHODS:
1. Extraction of Neem oil:
Materials used: Neem seeds were washed properly prior to extraction to eliminate impurities and dried in an oven at 50°C to a uniform moisture content. The dried seeds were ground and sieved to a homogeneous particle size of 355μm.
Equipment:
Drying oven, analytical balance, sieve shaker, Soxhlet extractor, heater mantle, filter paper, and standard lab glassware, including conical flasks, volumetric flasks, beakers, burettes, and pipettes. Set of sieves sizes arranged in descending order mm, 710μm and 355μm.
Chemicals: n-hexane, methanol, ethanol, and mixtures of ethanol and hexane (60:40 and 40:60 by volume) for the extraction process. Alcoholic potassium hydroxide (KOH), hydrochloric acid (HCl), and phenolphthalein were used for determining oil quality parameters.
Method: 20grams of neem seed powder were loaded in a thimble and placed inside the Soxhlet extractor. 103 mL of the chosen solvent was transferred to a round-bottom flask that was connected to the extractor. The apparatus was heated to 70°C, and extraction was permitted for a maximum of three hours. The solvent was removed by evaporation using a water bath after extraction, leaving the neem oil behind. The quantity obtained of Neem oil is 10ml.11
Figure 1: Extraction of Neem oil by Soxhlet Apparatus.
2. Formulation of Emulgel:
The synthetic drug aspirin is obtained in pure powder form, and a herbal drug Neem oil is extracted from neem seeds through the Soxhlet extraction method. All other chemicals were used without any further chemical modification.
Composition of different formulation batches: (Table-1)
Preperation of emulgel:
1) Gel preparation-
The required amount of filtered water was added to the Carbopol gel, which was then continuously stirred at a moderate speed and allowed to soak overnight.
2) Emulsion Phase-
Preparation of aqueous phase – In distilled water, dissolve the required quantity of Tween 20.
Preparation of oily phase – Dissolve the required amount of Span 20 in paraffin oil, then add the appropriate amount of Neem oil and Mentha oil.
3) Preparation of emulsion-
Triturate an appropriate amount of aspirin in a mortar and pestle. Then add methylparaben and propylene glycol. After mixing it properly, add the previously prepared oil phase into it. Then, triturate it for 5 minutes. Later, add this oil phase into the aqueous phase dropwise with continuous stirring on a magnetic stirrer (50°C). Then stir it for 3-4 hours until it becomes a homogeneous mixture.
4) Preparation of Emulgel-
In this stage, add the prepared emulsion into the soaked carbopol gel with continuous stirring. The magnetic stirrer is used at 50°C until it becomes concentrated.12
The emulgel was formulated by this method of preparation to develop a stable and effective topical formulation. Three different formulation batches F1, F2, and F3, were prepared. Among the three, Batch F1 was identified as the most promising formulation. It demonstrated excellent stability over time, with no signs of phase separation or degradation. The consistency of Batch F1 was smooth and uniform, making it suitable for application and ensuring proper drug delivery through the skin. In contrast, Batches F2 and F3 showed several undesirable characteristics. Both exhibited signs of phase separation, indicating poor emulsion stability. Their consistencies were uneven and lacked the smooth, gel-like texture required for effective topical use. Based on these observations, Batch F1 was selected for further evaluation and potential development.
Table 1: Composition of different formulation batches.
|
Sr. No. |
Ingredients |
Activity |
F1 |
F2 |
F3 |
Concentrations |
|
1 |
Aspirin |
Active ingredient |
1.5 |
2.0 |
2.5 |
w/w |
|
2 |
Neem oil |
Active ingredient |
1.0 |
1.2 |
1.5 |
w/v |
|
3 |
Carbopol 930 |
Gelling agent |
0.5 |
0.7 |
1.0 |
w/w |
|
4 |
Tween 20 |
Surfactant |
2.0 |
2.5 |
3.0 |
w/v |
|
5 |
Span 20 |
Surfactant |
1.5 |
1.8 |
2.0 |
w/v |
|
6 |
Methyl paraben |
Preservative |
0.02 |
0.02 |
0.02 |
w/w |
|
7 |
Liquid paraffin |
Oil phase |
4.0 |
5.0 |
6.0 |
w/v |
|
8 |
Propylene glycol |
Humectant |
5.0 |
6.0 |
7.0 |
w/v |
|
9 |
Mentha oil |
Penetration enhancer |
0.4 |
0.5 |
0.6 |
w/v |
|
10 |
Water |
Solvent |
q.s to 100 |
q.s to 100 |
q.s to 100 |
q.s |
EVALUATION PARAMETERS:
a) Appearance:
The formulated emulgel was visually examined to assess its colour, odour, texture, and consistency.12
b) Ph:
The glass electrode was dipped into 10 milliliters of pure water that had been diluted with one gram of emulgel. Each formulation's pH was assessed three times, and the average result was determined.13
c) Viscosity:
A Brookfield digital viscometer (DV-III ultra) fitted with spindle number 64 was used to measure the viscosity of the prepared samples at room temperature. A beaker was filled with the formulation whose viscosity needed to be ascertained. The reading was recorded once the spindle was free to move within the emulgel.14
d) Stability study:
The stability is studied at high temperature and freezing temperature. At high temperature in a hot air oven, the emulgel is placed at 60°C for 2,4 and 8hours and at freezing temperature at 2-80C for 3-8hours.12
e) Spreadability:
For the spreadability test, both glass slides and skin surfaces were used to evaluate the emulgel. Two drops of the emulgel were placed on a glass slide, followed by another slide of the same size placed on top. The top slide was then moved toward the edge to assess how easily the emulgel spread. The emulgel demonstrated uniform spreadability. When applied to the skin, it is distributed evenly without any grittiness.12
f) Extrudability study:
The force required to force the emulgel out of the tube is used to measure it. The method for figuring out the applied shear in the rheogram's region that corresponds to a shear rate higher than the yield value and has plug flow afterward. After applying the weight in grams required to extrude a minimum of 0.5cm of emulgel ribbon in 10seconds, emulgel is forced out of a lacquered aluminum collapsible tube. A larger amount is extruded for better extrudability. Extrudability is determined by doing the procedure in triplicate and calculating the average values. The following formula is then used to determine the extrudability:
Weight applied to extrude emulgel from tube (in gm)
Extrudability = –––––––––––––––––––––––––––––––––––
Area (in cm2)15
g) In vitro release study:
To study drug release in vitro, a modified Franz diffusion (FD) cell was used. A dialysis membrane sandwiched between the FD cell's donor and receptor compartments was coated with the emulgel. As the dissolving medium, phosphate buffer (pH 7.4) was utilized. A circulating water jacket was used to keep the temperature at 37°C. A magnetic bead supplied constant stirring while the entire apparatus was set up on a magnetic stirrer. As a control, a blank sample was run concurrently. Five milliliters of samples were taken out at prearranged intervals and promptly replaced with an equivalent volume of brand-new buffer. UV spectrophotometry was used to analyze the samples at 285 nm, and the cumulative proportion of medication released was computed. The real release of the medication was ascertained by taking the test readings and subtracting the control values.16
h) Anti-bacterial activity of Neem oil:
Sample Preparation: A stock solution with a concentration of 100mg/mL was created by combining 5 g of oil with 0.5mL of DMSO (Dimethyl Sulfoxide), followed by diluting the resulting mixture to a final volume of 50mL using distilled water. From this stock solution, five distinct concentrations (5, 20, 50, 80, and 100mg/mL) were generated through a series of dilutions. Streptomycin was utilized as the positive control, while 1% DMSO (Dimethyl Sulfoxide) and distilled water acted as negative controls. These samples were produced in three formulation batches identified as F1, F2, and F3.
Bacterial Strains: The bacterium Escherichia coli is utilized for testing antibacterial activity. It is subcultured and kept at 35±2°C to grow pure colonies for the experiment.
Preparation of Medium:
To create nutrient agar, 13.48 grams of agar powder were combined with 480 milliliters of distilled water and heated to a boil while stirring continuously. The mixture was then sterilized using an autoclave set to 121°C for a duration of 15minutes. Following sterilization, the liquid agar was poured into petri dishes to achieve a consistent depth of 4 millimeters, left to solidify at room temperature, and stored upside down in a refrigerator at 4–8°C until it was ready for use.
Determination of Antibacterial Activity:
The antibacterial qualities of the test material against E. coli were evaluated using a modified disc diffusion method. Five E. Coli colonies were mixed with two milliliters of sterile saline and vortexed to ensure homogeneity to make a bacterial suspension. A sterile swab was used to evenly distribute the inoculum onto agar plates while spinning in a methodical manner. Sterile filter paper discs were put on the agar and infused with 10µL of the test sample after it had rested for three to five minutes. The discs were then left to air dry. After 24 and 48hours of incubation at 35±2°C, the zones of inhibition were measured in millimeters. In order to guarantee accuracy, this process was carried out three times.17
RESULT AND DISCUSSION:
Physical Evaluation:
The observed emulgel compositions had a pleasant, aromatic smell and were white in color. Its semi-solid consistency, good viscosity, and smooth texture demonstrated appropriate formulation, physical stability, and topical application appropriateness.
Measurement of pH:
Three different trials give pH values for formulation F1 of 5.45, 5.47, and 5.46, with an average of 5.46. The emulgel's slightly acidic pH level, which is within the typical skin pH range of 4.5 to 6.5, makes it suitable for topical use. By doing this, the formulation's compatibility with the epidermis is enhanced, and the likelihood of skin irritation is decreased.
Viscosity:
Using a Brookfield viscometer, the emulgel's viscosity was ascertained. Spindle 64 was used for the measurement, and it rotated at 60rpm. At room temperature, the measured viscosity was 6789 centipoises (cP). It suggests a thick and slow-flowing nature by indicating a high viscosity.
Stability studies:
a) At high temperature (60ºC)
Table 2: Stability at high temperature.
|
Temperature |
Hours |
|||
|
2hr |
4hr |
8hr |
24hr |
|
|
60oC |
No phase separation |
No phase separation |
No phase separation |
No phase seperation |
The prepared emulgel is kept in hot air oven at 600C for 2, 4, 8 hours and 24 respectively. There is no phase seperation after observing the formulation
b) At low temperature (2-8ºC)
Table 3: Stability at low temperature.
|
Hours |
Outcome |
|
2hr |
Stability with no phase separation |
|
4hr |
Stability is seen with the freezing of emulgel |
|
8hr |
Completely frozen but no phase separation |
|
45 days |
Completely frozen but no phase separation |
The prepared formulation is kept in a refrigerator at 2-80C for 2, 4, 8hours and 45 days as per the resources available. The outcomes observed are stability with no phase seperation, freezing of emulgel and completely frozen but no phase seperation respectively.
Spreadability:
The formulation showed good spreadability on the skin's surface as well as on glass slides. For optimal drug administration on the skin, easy application, and even dispersion, effective spreadability is essential. By making the product more enjoyable to use, it also increases patient adherence.
Exctrudability study:
Table 4: Extrudability of Emulgel.
|
Formulation |
Extrudability |
|
F1 |
17.79 cm3/s |
This value suggests that the emulgel can be effortlessly squeezed from the container, providing convenience for users. Excellent extrudability guarantees accurate dosing and reduces waste of formulation.
In vitro release study:
The skin permeation study was carried out to assess the transdermal absorption of formulation for 4hours. The absorbance values, which show the amount of drug permeated through the skin, were measured at various time intervals and plotted accordingly. The instrument type which is used to determine absorbance is the UV-1800 Series with a wavelength of 340.0nm.
At the initial time point (5 minutes), the absorbance was 1.312, indicating a relatively high initial permeation. However, a decrease was observed at 10minutes (1.111), which shows a short lag phase or possible initial saturation or binding of the drug within the superficial skin layers. A minimal increase was seen at 15minutes (1.121), indicating the beginning of a gradual diffusion phase. Due to this, the absorbance is stable from 10 to 15minutes. From 30 minutes onwards, the absorbance steadily increased, reaching 1.241 at 30minutes and continuing to rise to 1.371 at 60minutes. This upward trend shows a consistent permeation of the drug through the skin layers. At 2 hours, the absorbance reached 1.514 and further increased to a peak of 1.571 at 3hours, demonstrating maximum permeation at this time point. This could indicate the best time for drug absorption through the skin. However, a slight decline in absorbance was observed at 4 hours (1.411), possibly due to drug degradation or saturation of the permeation medium.
Overall, the study indicates that the formulation shows effective skin permeation, with maximum absorption occurring at around 3 hours. The initial decline followed by a sustained increase shows a biphasic permeation pattern, possibly influenced by formulation components and skin barrier properties.
The graphical representation of skin permeation study are given below:
Figure 2: Skin Permeation Study.
Anti-bacterial activity:
Table 5: Anti-bacterial activity.
|
Concentration (mg/mL) |
Zone of inhibition (E.coli) (mm) |
|
5 |
7.2 |
|
20 |
9.1 |
|
50 |
10.8 |
|
80 |
11.2 |
|
100 |
11.9 |
|
Control (DMSO/Water) |
0 |
The bioassay on antibacterial activity revealed that Azadirachta indica (A. indica) seed fixed oil inhibited the growth of the Gram-negative bacterium E. coli. The maximum zone of inhibition observed was 11.9 mm at a concentration of 100mg/mL after 48 hours of exposure. Other concentrations of the seed fixed oil showed inhibition zones of 7.2mm, 9.1mm, 10.8mm, and 11.2 mm at 5, 20, 50, and 80mg/mL respectively after 48 hours. The negative controls, 1% DMSO and distilled water, showed no antibacterial activity with zero inhibition recorded.
CONCLUSION:
The formulation of a combined aspirin and neem oil emulgel successfully achieved the study’s objectives by demonstrating desirable physicochemical properties, effective skin permeation, and significant antimicrobial activity. The optimized F1 batch exhibited ideal characteristics in terms of pH (5.46), high viscosity (6789 cP), smooth spreadability, and good extrudability (17.79cm³/s). The stability study performed in two conditions at 600C and 2-80C for 2, 4, 8 and 24hours at high temperature and 2, 4, 8hours and 45 days. In vitro permeation studies confirmed sustained drug release with peak absorption at around three hours, supporting its potential for prolonged topical action. Importantly, antibacterial testing revealed that neem oil exhibited a clear inhibitory effect against Escherichia coli, with a maximum zone of inhibition of 11.9mm at 100mg/mL concentration. This confirms the formulation’s potential for infection control in wound care applications.
By combining aspirin’s anti-inflammatory and analgesic effects with neem oil’s antimicrobial and regenerative properties, this emulgel provides a promising dual-action therapy for managing localized inflammation and preventing bacterial infections. It represents a valuable alternative to conventional topical treatments, offering enhanced safety and efficacy through the integration of synthetic and herbal medicine. Further in vivo and clinical studies are recommended to confirm its therapeutic utility and safety in broader patient populations
REFERENCES:
1. Ugurlucan M, Caglar IM, Turhan Caglar FN, Ziyade S, Karatepe O, Yildiz Y, et al. Aspirin: from a Historical Perspective. Vol. 7, Recent Patents on Cardiovascular Drug Discovery. 2012.
2. Fuster V, Sweeny JM. Aspirin: A historical and contemporary therapeutic overview. Vol. 123, Circulation. 2011. p. 768–78.
3. Campos EVR, de Oliveira JL, Pascoli M, de Lima R, Fraceto LF. Neem oil and crop protection: From now to the future. Front Plant Sci. 2016 Oct 13;7(OCTOBER2016).
4. Medicinal Properties of Neem Leaves: A Review.
5. Talat M, Zaman M, Khan R, Jamshaid M, Akhtar M, Mirza AZ. Emulgel: an effective drug delivery system. Drug Development and Industrial Pharmacy. 2021; 47: 1193–9.
6. Haneefa Kpm, Easo S, Prasad Mohanta G, Nayar C. Emulgel: An Advanced Review.
7. Phad AR, Dilip NT, Sundara Ganapathy R. Emulgel: A Comprehensive Review for Topical Delivery of Hydrophobic Drugs. Asian Journal of Pharmaceutics. Vol. 12,
8. DrugBank Online | Database for Drug and Drug Target Info). Mechanism of action of Aspirin.
9. Phytoconstituents.
10. Samir MI. Research. Int J of Pharm Sci [Internet]. 2025;3:1523–38. Available from: https://www.ijpsjournal.com
11. Tesfaye B, Tefera T. Extraction of Essential Oil from Neem Seed by Using Soxhlet Extraction Methods. International Journal of Advanced Engineering, Management and Science. 2017; 3(6):646–50.
12. Rani N, Ghadge M, Singh Chaudhary P, Professor A. Development and Assessment of Aspirin Emulgel for Ischemic Stroke Management. Journal of Namibian Studies. 2023; 33–5.
13. ajptonline.com_HTML_Papers_Asian Journal of Pharmacy and Technology__PID__2021-11-3-5.
14. Singh RP, Parpani S, Narke R, Chavan R. Emulgel: A Recent Approach for Topical Drug Delivery System. Asian Journal of Pharmaceutical Research and Development (An International Peer-Reviewed Journal of Pharmaceutical Research and Development [Internet]. 2(2): 112–23. Available from: www.ajprd.comwww.ajprd.com
15. Bongoni RN. Formulation And Evaluation of Ornidazole Topical Emulgel. Article in World Journal of Pharmacy and Pharmaceutical Sciences [Internet]. 2019; Available from: www.wjpps.com
16. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharmaceutical Journal. 2012 Jan; 20(1): 63–7.
17. Sandanasamy O, Hamid Nour A, Nizam Bin Tajuddin S, Hamid Nour A. Send Orders for Reprints to reprints@benthamscience.net The Open Conference Proceedings Fatty Acid Composition and Antibacterial Activity of Neem (Azadirachta indica) Seed Oil. Journal. 2013.
|
Received on 11.06.2025 Revised on 15.11.2025 Accepted on 26.02.2026 Published on 05.10.2026 Available online from October 12, 2026 Asian J. Res. Pharm. Sci. 2026; 16(4):333-338. DOI: 10.52711/2231-5659.2026.00049 ©Asian Pharma Press All Right Reserved
|
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License. |
|